Cardiac Rehabilitation Individualized Healing for Patients with Cardiovascular Disease
|
|
- MargaretMargaret Pitts
- 6 years ago
- Views:
Transcription
1 Cardiac Rehabilitation Individualized Healing for Patients with Cardiovascular Disease Richard A. Josephson MS, MD FACC, FAHA, FACP, FAACVPR Director of Cardiac Intensive Care Director of Cardiovascular and Pulmonary Rehabilitation University Hospitals, Cleveland Professor of Medicine CWRU
2 Treatment vs. Healing TREATMENT The act or manner or an instance of treating someone or something The techniques or actions customarily applied in a specified situation HEALING To become healthy or well again To make (someone or something) healthy or well again Miriam Webster Dictionary
3 CVD Secondary Prevention with Medication Reduction of BP with a variety of drugs Lipid lowering with statins Antithrombotic treatment with aspirin or clopidogrel Blockade of the RAAS with a variety of agents Blockade of the SNS with beta blockers..are beneficial in a wide spectrum of patients They each produce, in general, approximately a % RRR in CV events over a period of 2-5 years.
4 Benefits of Cardiac Rehabilitation-Then Meta-analysis of 32 randomized trials 8440 patients, mean age 55 yrs, >90% male Trials between , varied regimens Exercise-based rehab for patients with CAD Issues with methodology, data reporting, changing therapy Improved LDL, TG, BP, Reduced Tobacco Use Decreased Mortality: Total mortality OR 0.73 ( ) CV mortality OR 0.69 ( ) RRR ~ 30% 2001 Jollife J, et al. Cochrane Database Syst Rev
5 Benefits of Cardiac Rehabilitation-Now Dramatic Reduction in Mortality 30% CR users Non-CR users 24.6% 30% CR 25 plus sessions CR 1-24 sessions Cumulative mortality rate 20% 10% 0% Absolute: 8.3% Relative: 33.7% 5.3% 2.2% 10.1% 5.2% 14.8% 8.5% 19.6% 12.2% Months from discharge 16.3% Cumulative mortality rate 20% 10% 0% More CR is better! Absolute: 3.2% Relative: 19% 2.6% 1.1% 5.6% 3.6% 9.2% 6.4% 13.1% 10.0% 17.2% Months from discharge 14.0%
6 Cardiac Rehabilitation means a physician-supervised program that furnishes physician prescribed Exercise Cardiac risk factor modification Psychosocial assessment Outcomes assessment Individualized Treatment Plan (ITP) means a written plan tailored to each individual patient that includes Diagnosis Type, Amount, Frequency, Duration of Services Goals set for the Individual Federal Register Vol. 74 No
7 Exercise is Medicine Increases Exercise Capacity Cardiac Output Tissue 02 Extraction V02 Maximum Endothelial Function Plasminogen Activator HDL Cholesterol Insulin Sensitivity Bone Mass Cognitive Function Decreases Mortality Recovery HR Resting BP Fibrinogen C-Reactive Protein LDL Cholesterol Triglycerides Body Weight Depression Disability
8 UH Cardiac Rehab Program Individualized Risk Assessment Individualized Exercise Prescription Monitored Exercise (including telemetry) Educational Program Access to Smoking Cessation Program Psychological evaluation and treatment as appropriate Monitoring of individual patient and goals Comprehensive discharge prescription Communication and interaction with physicians
9 UH Cardiac Rehab Education Nutrition lipids, salt, prudent diet, weight loss, label reading, dining in restaurants Cardiac anatomy and physiology Cardiac terms and diagnoses Cardiac procedures Cardiac drugs Smoking cessation Psychosocial, stress, sex Work activity Lifetime healthy lifestyle program
10 Cardiac Rehabilitation Referral & ITP Process Inpatient or Outpatient Physician Order for CR CR Team Drafts Initial ITP ITP Review and Signature by Physician CR Team Drafts 30 Day ITP ITP Review and Signature by Physician
11 CR Prescriptions/ITPs Dr. Signature Dr. Signature Available via paper, fax, , AEMR
12 Cardiac Rehabilitation-Heart Failure Medicare Approval 2014 Large Evidence Base Proving Benefit Exercise Capacity Quality of Life LV structural and functional remodeling
13 Cardiac Rehabilitation-Heart Failure Systolic HF LVEF < 35% Optimal medical therapy (unspecified) Stable on tx for 6 weeks No planned proceedures (e.g. BivICD, surgery)
14 Cardiac Rehabilitation-Heart Failure UH Individualized Approach Medical Hx, Exam Baseline Multidimensional Questionnaires CPX Testing Exercise Prescription including: Strength Training High Intensity Interval Training
15 Cardiac Rehabilitation-Heart Failure What about everyone else? Phase 2-if another qualifying dx Phase 3 Approx $65/month Higher staff/pt ratio
16 Benefits of Cardiac Rehabilitation Diagnosis Functional QOL Morbidity Mortality Capacity AMI CABG Surgery Chronic Stable Angina PCI ? CHF Cardiac Transplant Heart Valve Surgery ?? ?? Williams MA, et al. Am Heart J 2006;152:835-41
17 Evidence for Cardiac Rehabilitation Current ACC/AHA Guidelines Post CABG STEMI NSTEMI Stable Angina PCI Heart Failure Class I, Level B Class I, Level C Class I, Level B Class I, Level B Class I, Level B Class IIa, Level B ACC/AHA Clinical Practice Guidelines
18 UH Cardiovascular & Pulmonary Rehabilitation Case CR PR Chagrin CR PR Conneaut CR PR Elyria CR PR Geauga CR PR Mentor CR PR Parma CR PR
19
20 References King M, Bittner V, Josephson R, Lui K, Thomas RJ, Williams MA., Medical Director Responsibilities for Outpatient Cardiac Rehabilitation/Secondardy Prevention Programs: 2012 Update: A Statement for Health Care Professsonals from The American Association for Cardiovascular and Pulmonary Rehabilitation and The American Heart Association. Circulation Nov 20; 126 (21): PubMed PMID: Josephson, R, and J. Weingart, Cardiac Rehabilitation Update to Chapter 67 Rehabilitation of the Patient with Coronary Heart Disease. Fuster, V., O Rourke, R. A., Walsh, R. A., Poole-Wilson, P,, Editors, King, S. B., Roberts, R., Nash. I. S., Prystowsky, E. N., Associate Editors: Hurst s The Heart, 12 th Edition: July htttp:// Cochrane Database Syst Rev Apr 27;4:CD doi: / CD pub4.Exercise-based rehabilitation for heart failure.taylor RS1, Sagar VA, Davies EJ, Briscoe S, Coats AJ, Dalal H, Lough F, Rees K, Singh S. Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease, Philip A. Ades, M.D., N Engl J Med 2001; 345: September 20, 2001DOI: /NEJMra Carl J. Lavie, Richard V. Milani. (2011) Cardiac Rehabilitation and Exercise Training in Secondary Coronary Heart Disease Prevention. Progress in Cardiovascular Diseases 53:6, JAMA Apr 8;301(14): doi: /jama Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.o'connor CM1, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Piña IL; HF- ACTION Investigators.
The Role of Cardiac Rehabilitation in Recovery & Secondary Prevention. Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager
The Role of Cardiac Rehabilitation in Recovery & Secondary Prevention Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager Objectives Core Components of Cardiac Rehab Program CR Indications &
More informationThe importance of follow-up after a cardiac event: CARDIAC REHABILITATION. Dr. Guy Letcher
The importance of follow-up after a cardiac event: CARDIAC REHABILITATION Dr. Guy Letcher The National Medicare Experience Mortality After Angioplasty 225,915 patients Mortality After Bypass Surgery 357,885
More informationProgram Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name
Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.
More informationPractice-Level Executive Summary Report
PINNACLE Registry Metrics 0003, Test Practice_NextGen [Rolling: 1st April 2015 to 31st March 2016 ] Generated on 5/11/2016 11:37:35 AM American College of Cardiology Foundation National Cardiovascular
More informationQuality Payment Program: Cardiology Specialty Measure Set
Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor
More informationPopulations Interventions Comparators Outcomes Individuals: With diagnosed heart disease. rehabilitation
Protocol Cardiac Rehabilitation in the Outpatient Setting (80308) Medical Benefit Effective Date: 01/01/17 Next Review Date: 05/18 Preauthorization No Review Dates: 07/07, 07/08, 05/09, 05/10, 05/11, 05/12,
More informationThe Best Kept Secret in Your Medical Neighborhood. Evidence Based Cardiac and Pulmonary Rehabilitation
The Best Kept Secret in Your Medical Neighborhood Evidence Based Cardiac and Pulmonary Rehabilitation Marjorie King, MD, FACC, MAACVPR Past President, AACVPR Chief Medical Officer Helen Hayes Hospital
More informationQuality Payment Program: Cardiology Specialty Measure Set
Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for
More informationMeasurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)
Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for Artery, Atrial Fibrillation, Hypertension
More informationPerformance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set
Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer
More informationThe Role of Cardiac Rehabilitation. The Role of Cardiac Rehabilitation. in Heart Failure. in Heart Failure. History of Cardiac Rehab.
The Role of Cardiac Rehabilitation The Role of Cardiac Rehabilitation in Heart Failure in Heart Failure Kate Traynor RN MS FAACVPR Financial Disclosures No relevant financial relationship exists. History
More informationNew PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.
New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0. Measure Steward Measure Name Measure Description Rationale for Adding
More informationLong-Term Management Of the ACS Patient: State-of-the-Art. Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA
Long-Term Management Of the ACS Patient: State-of-the-Art Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA Disclosures I have no disclosures. Case Study 45 y/o male admitted to
More informationCardiac Rehabilitation for Heart Failure Patients. Jia Shen MD, MPH Assistant Professor of Medicine UC San Diego Health System
Cardiac Rehabilitation for Heart Failure Patients Jia Shen MD, MPH Assistant Professor of Medicine UC San Diego Health System Disclosures There are no conflict of interests related to this presentation.
More information3/25/2013. Secondary Prevention of CAD: What Works? Disclosures. Overview. None. 3 things to know 1 thing to do Questions
Secondary Prevention of CAD: What Works? Randal J. Thomas, MD, MS Director Cardiovascular Health Clinic Mayo Clinic Rochester, Minnesota Disclosures None Overview 3 things to know 1 thing to do Questions
More informationSubject: Outpatient Phase Ii Cardiac Rehab Individualized Treatment Plan And Exercise Prescription
CARDIAC REHAB POLICY & PROCEDURES Policy #: CR 208 Subject: Outpatient Phase Ii Cardiac Rehab Individualized Treatment Plan And Exercise Prescription Purpose: To establish guidelines for developing and
More informationBeta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National
More informationControversies in Cardiac Pharmacology
Controversies in Cardiac Pharmacology Thomas D. Conley, MD FACC FSCAI Disclosures I have no relevant relationships with commercial interests to disclose. 1 Doc, do I really need to take all these medicines?
More informationValue of Cardiac Rehabilitation for Improving Patient Outcomes
Value of Cardiac Rehabilitation for Improving Patient Outcomes Pam R. Taub MD, FACC Director of Step Family Cardiac Wellness and Rehabilitation Center Associate Professor of Medicine UC San Diego Health
More informationCARDIAC REHABILITATION
CARDIAC REHABILITATION A N A B A R A C M D, P H D M E D S T A R H E A R T A N D V A S C U L A R I N S T I T U T E, M E D S T A R W A S H I N G T O N H O S P I T A L C E N T E R OBJECTIVES Rationale for
More informationCured of Cancer but now Let s Heal the Heart An exploration into the effects of cancer on the heart
Cured of Cancer but now Let s Heal the Heart An exploration into the effects of cancer on the heart Suma H. Konety, MD, MS Associate Professor, Cardiovascular Division University of Minnesota What is Cardio-Oncology?
More informationCardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003
Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,
More informationClinical Policy Title: Cardiac rehabilitation
Clinical Policy Title: Cardiac rehabilitation Clinical Policy Number: 04.02.02 Effective Date: September 1, 2013 Initial Review Date: February 19, 2013 Most Recent Review Date: February 6, 2018 Next Review
More information11/19/2013. Cardiac Rehabilitation Coverage and Documentation Requirements. Phases of Cardiac Rehabilitation. Phase II
Cardiac Rehabilitation Coverage and Documentation Requirements Phases of Cardiac Rehabilitation Phase I: Acute in-hospital phase of CR Phase II: is the initial outpatient phase of the program Phase III:
More informationDavid A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio
1 STABLE ISCHEMIC HEART DISEASE: A NON-INVASIVE CARDIOLOGIST S PERSECTIVE 2018 Cardiovascular Course for Trainees and Early Career Physicians APRIL 20, 2018 David A. Orsinelli, MD, FACC, FASE Professor,
More informationCORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW
CONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN CONARY ARTERY DISEASE (CAD) MEASURES GROUP: #6. Coronary Artery Disease (CAD): Antiplatelet
More informationRebuilding and Reinvigorating Cardiac Rehabilitation in 2018
Rebuilding and Reinvigorating Cardiac Rehabilitation in 2018 Pam R. Taub MD, FACC Director of Step Family Cardiac Wellness and Rehabilitation Center Associate Professor of Medicine UC San Diego Health
More informationCardiac Rehabilitation Should be Paid in Korea?
Cardiac Rehabilitation Should be Paid in Korea? Cardiac prevention & Rehabilitation Center, Heart Institute, Asan Medical Center, Seoul, Korea Jong-Young Lee, MD. NO CONFLICT OF INTEREST TO DECLARE Before
More informationPatient Navigator Program: Focus MI Diplomat Hospital Metrics
Patient Navigator Program: Focus MI Diplomat Hospital Metrics Goal Statement: To reduce avoidable hospital readmissions for patients discharged with acute myocardial infarction (AMI) by supporting a culture
More informationAACVPR/ACC/AHA PERFORMANCE MEASURES. Neil Oldridge, PHD, FAACVPR Ileana L. Piña, MD, FACC John Spertus, MD, MPH, FACC
Journal of the American College of Cardiology 2007 by the American Association of Cardiovascular and Pulmonary Rehabilitation, Vol. 50, No. 14, 2007 American College of Cardiology and American Heart Association,
More informationConsensus Core Set: Cardiovascular Measures Version 1.0
Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized
More informationThe Clinical Unmet need in the patient with Diabetes and ACS
The Clinical Unmet need in the patient with Diabetes and ACS Professor Kausik Ray (UK) BSc(hons), MBChB, MD, MPhil, FRCP (lon), FRCP (ed), FACC, FESC, FAHA Diabetes is a global public health challenge
More informationPreventive Cardiology
Preventive Cardiology 21 Volume The Preventive Cardiology and Rehabilitation Prevention Outpatient Visits 7,876 Program helps patients identify traditional and Phase I Rehab 9,932 emerging nontraditional
More informationHypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic
Hypertension in 2015: SPRINT-ing ahead of JNC-8 MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic Conflits of interest? None Disclaimer The opinions contained herein are not to be considered
More informationPreventive Cardiology Scientific evidence
Preventive Cardiology Scientific evidence Professor David A Wood Garfield Weston Professor of Cardiovascular Medicine International Centre for Circulatory Health Imperial College London Primary prevention
More informationAfter modern CABG: Pro.
Is there a role for cardiac rehabilitation in the modern era of PCI and CABG? After modern CABG: Pro. Massimo F. Piepoli, Italy No conflict of interest Modern CABG: MICS CABG (Minimally Invasive Cardiac
More information2/11/2017. Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox. Disclosures. Carl J. Lavie, MD, FACC, FACP, FCCP
Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox Carl J. Lavie, MD, FACC, FACP, FCCP Professor of Medicine Medical Director, Cardiac Rehabilitation and Preventive Cardiology
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Cardiac Rehabilitation in the Outpatient Setting Page 1 of 16 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Cardiac Rehabilitation in the Outpatient Setting Professional
More informationPrimary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group
Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to
More informationTHE NATIONAL QUALITY FORUM
THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use
More informationAcute Coronary Syndromes: Different Continents, Different Guidelines?
Acute Coronary Syndromes: Different Continents, Different Guidelines? Robert A. Harrington MD, MACC, FAHA, FESC Arthur L. Bloomfield Professor of Medicine Chair, Department of Medicine Stanford University
More information2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction Ramzi Khalil MD FACC Assistant Professor Allegheny Gen.Hospital AHN Speakers
More informationConsensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0
Consensus Core Set: ACO and PCMH / Primary Care s 0018 Controlling High Blood Pressure patients 18 to 85 years of age who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately
More informationCardiac Rehabilitation in the Outpatient Setting. Description
Subject: Cardiac Rehabilitation in the Outpatient Setting Page: 1 of 10 Last Review Status/Date: September 2014 Cardiac Rehabilitation in the Outpatient Setting Description Cardiac rehabilitation refers
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Cardiac Rehabilitation in the Outpatient Setting Page 1 of 17 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Cardiac Rehabilitation in the Outpatient Setting Professional
More informationMEDICAL POLICY SUBJECT: CARDIAC REHABILITATION
MEDICAL POLICY PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW
ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):
More information2016 Internal Medicine Preferred Specialty Measure Set
1 0059 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%): Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period 5 0081 Registry, EHR, 9 0105
More informationNHS QIS National Measurement of Audit Acute Coronary Syndrome
NHS QIS National Measurement of Audit Acute Coronary Syndrome Things have changed based on the experience and feedback from the first cycle of measurement and, for the better we think! The Acute Coronary
More informationCardiac Rehabilitation The Evidence Base & Implications for Practice
Cardiac Rehabilitation The Evidence Base & Implications for Practice Rod Taylor MSc, PhD Dept of Public Health & Epidemiology University of Birmingham Bisperbjerg Hospital, Copenhagen 11 th & 12 th December
More informationA multicenter tobacco cessation program in acute coronary syndrome
A multicenter tobacco cessation program in acute coronary syndrome PD Nicolas Rodondi, MD, MAS Research Fellow: Reto Auer, MD Head of the Cardiovascular Prevention & Lipid Clinic Department of Ambulatory
More informationIs it ever too late for cardiovascular prevention and rehabilitation? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany
Is it ever too late for cardiovascular prevention and rehabilitation? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany The demographic issue Life expectancy is increasing Patients are getting
More informationWomen and Vascular Disease
Women and Vascular Disease KEVIN F. REBECK PA-C VASCULAR TRANSPLANT SURGERY 1 The Scope of the Problem One woman dies every minute from cardiovascular disease in the U.S.! The Scope of the Problem CVD
More informationWhat have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline?
What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline? Salim S. Virani, MD, PhD, FACC, FAHA Associate Professor, Section of Cardiovascular Research Baylor
More informationNo relevant financial relationships
MANAGEMENT OF LIPID DISORDERS Balancing Benefits and harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial relationships baron@medicine.ucsf.edu
More informationEnvironmental. Vascular / Tissue. Metabolics
Global Risk Reduction--WINS Picking Mom and Dad-2016 Environmental Vascular / Tissue Metabolics Stop smoking-1b Physical activity-1b Weight control-1b Chelation therapy-3c Influenza vaccination-1b Blood
More informationDo Women Benefit From Statins for Primary Prevention?: Controversy, Challenges and Consensus
Do Women Benefit From Statins for Primary Prevention?: Controversy, Challenges and Consensus C. Noel Bairey Merz MD, FACC, FAHA Professor and Women s Guild Endowed Chair Director, Barbra Streisand Women
More informationKnow the Quality of our Care at Every Step. Kansas City ACS Summit BI-State Cardiovascular Education Consortium
Know the Quality of our Care at Every Step Kansas City ACS Summit BI-State Cardiovascular Education Consortium Welcome to the Kansas City ACS Summit Objectives: Follow the flow and care of an ACS patient
More informationThe Future of Cardiac Care: Managing Our Patients Together
The Future of Cardiac Care: Managing Our Patients Together Charles R. Caldwell, MD, FACC Disclosures: iheartdoc,inc. Telemedicine 1 MACRA Medicare Access and CHIP Reauthorization Act of 2015 Repealed the
More informationGet With The Guidelines: Lessons for National Healthcare Improvement Programs
Get With The Guidelines: Lessons for National Healthcare Improvement Programs Gregg C. Fonarow, MD, FACC, FAHA, FHFSA Eliot Corday Professor of Cardiovascular Medicine and Science UCLA Division of Cardiology
More informationHEART FAILURE AN OMINOUS DISEASE
HEART FAILURE AN OMINOUS DISEASE Conflicts of Interest I Have No Conflicts of Interest to Disclose Objective At the conclusion of this presentation, the participants will be able to identify benefits and
More informationTable 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings
CMS-1345-P 174 Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings AIM: Better Care for Individuals 1. Patient/Care Giver Experience
More informationThe Gender Divide Women, Men and Heart Disease February 2017
The Gender Divide Women, Men and Heart Disease February 2017 Nandita S. Scott, MD FACC Co-Director MGH Heart Center Corrigan Women s Heart Health Program Massachusetts General Hospital Heart Disease For
More informationDecline in CV-Mortality
Lipids id 2013 What s Changed? Christopher Granger, MD Disclosure Research contracts: AstraZeneca, GSK, Merck, Sanofi- Aventis, BMS, Pfizer, The Medicines Company, Medtronic Foundation, and Boehringer
More informationWomen s Ischemia and cardiac rehabilitation
Women s Ischemia and cardiac rehabilitation Dr. Pallavi Bellamkonda MD, FACC Financial Disclosures: None 1 Objectives Understanding the Unique presentations of Ischemic Disease in Women: Obstructive Coronary
More informationCardiac Rehabilitation and Secondary Prevention:
Cardiac Rehabilitation and Secondary Prevention: Get Pumped Up About Heart Health Janice Anderson, RN, BSN, CCRP Manager, Cardiac Rehabilitation and Secondary Prevention Christiana Care Health System Statistics
More informationImplications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?
Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator
More informationRehabilitation for Cardiovascular Disease: Updates and Opportunities. Jonathan R. Murrow, MD Associate Professor of Medicine (Cardiology)
Rehabilitation for Cardiovascular Disease: Updates and Opportunities Jonathan R. Murrow, MD Associate Professor of Medicine (Cardiology) Disclosures Grants: American Heart Association Grant-in-Aid Novartis
More informationIndividualizing and Expanding Care ( Perspectives for the VCN from )
Cardiac Rehabilitation 2018: Individualizing and Expanding Care ( Perspectives for the VCN from 1984 2018) Philip A. Ades MD University of Vermont College of Medicine Director, CR and Preventive Cardiology
More informationH2H Early Follow-up Challenge: See You in 7. Webinar #1 Thursday, March 3, :00 pm 4:00 pm ET. Welcome
H2H Early Follow-up Challenge: See You in 7 Webinar #1 Thursday, March 3, 2011 3:00 pm 4:00 pm ET 1 Welcome Take Home Messages Renew your H2H commitment Participate in the first H2H Challenge Help build
More information4. Which survey program does your facility use to get your program designated by the state?
STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI
More informationDiabetes and the Heart
Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital
More informationAssociate Professor Gerry Devlin
Associate Professor Gerry Devlin Clinical Cardiologist and Interventional Cardiologist NZ Heart Foundation Hamilton 9:00-9:15 Secondary Prevention of IHD The Challenge of Secondary Prevention Associate
More informationOBJECTIVES. New Twist To Old Disease: Cardiovascular Update /9/2017. Prevention Pre-operative Coronary Artery Disease
New Twist To Old Disease: Cardiovascular Update 2017 Sridevi R Pitta, M.D.,MBA, F.S.C.A.I., R.P.V.I Medical Director for STEMI, Medical Director for CV Quality Council, Interventional Cardiologist & Endovascular
More informationCarl J. Lavie, MD, FACC, FACP, FCCP
Untangling the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox Carl J. Lavie, MD, FACC, FACP, FCCP Professor of Medicine Medical Director, Cardiac Rehabilitation and Preventive Cardiology
More informationAcute Coronary Syndrome. Sonny Achtchi, DO
Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification
More informationDiabetic Patients: Current Evidence of Revascularization
Diabetic Patients: Current Evidence of Revascularization Alexandra J. Lansky, MD Yale University School of Medicine University College of London The Problem with Diabetic Patients Endothelial dysfunction
More informationDisclosures. Preventing Heart Failure Re-admissions in Deaths Due to Cardiovascular Disease (United States: ) Heart Failure
29 th Annual Cardiology for Clinicians Spring Symposium Workshop #3 Alumni Hallway, Northeastern Conference Room, 1-9525 Thursday, May 5, 2016 Preventing Heart Failure Re-admissions in 2016 Leway Chen,
More informationAcute Myocardial Infarction
Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:
More informationUpdate on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines
Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease
More informationClinical Practice Guideline
Clinical Practice Guideline Secondary Prevention for Patients with Coronary and Other Vascular Disease Since the 2001 update of the American Heart Association (AHA)/American College of Cardiology (ACC)
More informationMEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/ Rehabilitation
MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION, 08/25/17 PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product,
More informationDIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN
DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and
More informationCardiac Rehabilitation after Primary Coronary Intervention CONTRA
DEBATE SESSION Is there a role for cardiac rehabilitation in the modern era of Percutaneous coronary intervention and coronary artery bypass grafting? Cardiac Rehabilitation after Primary Coronary Intervention
More informationUsing DOACs in CAD Patients in Sinus Ryhthm Results of the ATLAS ACS 2, COMPASS and COMMANDER-HF Trials
Using DOACs in CAD Patients in Sinus Ryhthm Results of the ATLAS ACS 2, COMPASS and COMMANDER-HF Trials 19 th Annual San Diego Heart Failure Symposium for Primary Care Physicians January 11-12, 2019 La
More informationPlanned Interventions
Risk Factors Exercise Diabetes Hypertension Tobacco Use Initial Status Patient is currently exercising: More than 150 minutes Less than 150 minutes Per Week Type 1 Type 2 Borderline Diabetic :HgA1c < 6.5%;
More informationProfessor Norman Sharpe. Heart Foundation West Coast
Professor Norman Sharpe Heart Foundation West Coast Primary Care the Keystone to Heart Health Improvement Norman Sharpe June 2013 The heart health continuum and the keystone position The culprit disease
More informationDiabetes and the Heart
Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with
More informationPRESENTED BY BECKY BLAAUW OCT 2011
PRESENTED BY BECKY BLAAUW OCT 2011 Introduction In 1990 top 5 causes of death and disease around the world: Lower Respiratory Tract Infections Diarrhea Conditions arising during pregnancy Major Depression
More informationCoronary Artery Disease in 2015: Acute Coronary Syndrome and beyond (Primary and Secondary Prevention of CAD)
Coronary Artery Disease in 2015: Acute Coronary Syndrome and beyond (Primary and Secondary Prevention of CAD) Andrew R. Waxler, MD, FACC Berks Cardiologists, Ltd. President Elect, Berks County Medical
More informationAdults With Diagnosed Diabetes
Adults With Diagnosed Diabetes 1990 No data available Less than 4% 4%-6% Above 6% Mokdad AH, et al. Diabetes Care. 2000;23(9):1278-1283. Adults With Diagnosed Diabetes 2000 4%-6% Above 6% Mokdad AH, et
More informationMeasure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner
2011 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current
More informationRCCO Quality Indicators Crosswalk
Aim: Better Care for Individuals (patient s perspective) RCCO Quality Indicators Crosswalk Quality Number 1. Access: timely care, appointments & info Denominator& Numerator ACO patients 18+ Data collection
More informationDisclosure. No relevant financial relationships. Placebo-Controlled Statin Trials
MANAGEMENT OF HYPERLIPIDEMIA AND CARDIOVASCULAR RISK IN WOMEN: Balancing Benefits and Harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationHigh Intensity Interval Exercise Training in Cardiac Rehabilitation
High Intensity Interval Exercise Training in Cardiac Rehabilitation Prof. Leonard S.W. Li Hon. Clinical Professor, Department of Medicine, The University of Hong Kong Director, Rehabilitation Virtus Medical
More informationStatins for Cardiovascular Disease Prevention in Women: Review of the Evidence
Statins for Cardiovascular Disease Prevention in Women: Review of the Evidence Karen E. Aspry, M.D., M.S., ABCL, FACC Assistant Professor of Medicine (Clinical) Alpert Medical School of Brown University
More informationTreatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center
Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment
More informationESC GUIDELINES ON DIABETES AND CARDIOVASCULAR DISEASES
ESC GUIDELINES ON DIABETES AND CARDIOVASCULAR DISEASES Pr. Michel KOMAJDA Institute of Cardiology - IHU ICAN Pitie Salpetriere Hospital - University Pierre and Marie Curie, Paris (France) DEFINITION A
More information